Home
Robert W. Duggan, Co-CEO: Summit Therapeutics SMMT Buy · Filed 25/10/23
Trade details
- Type
- Insider buy
- Amount
- $499,983.2
- Shares · price
- 26,680 sh · $18.74 a share
- Held after
- 76,680 sh
- Person
- Robert W. DugganCo-CEO
- Trade date
- 25/10/21
- Filed
- 25/10/23
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 3 insiders
- Holding change
- +53.4%
Summit Therapeutics trades, last 26 weeks
What else happened in Summit Therapeutics around then
Filed or reported within 30 days of the trade day · 25/09/21~25/11/20Robert W. Duggan's recent trades
- Robert W. Duggan
BuySummit Therapeutics
BuySummit Therapeutics
SMMT
$50M
3,810,000 sh
$50M
Filed 06/12
Traded 06/12
- Robert W. Duggan
BuySummit Therapeutics
BuySummit Therapeutics
SMMT
$1.5M
100,000 sh
$1.5M
Filed 06/04
Traded 06/04
- Robert W. Duggan
BuyPulse Biosciences
BuyPulse Biosciences
PLSE
$13M
660,233 sh
$13M
Filed 05/15
Traded 05/11
- Robert W. Duggan
BuyPulse Biosciences
BuyPulse Biosciences
PLSE
$13M
660,233 sh
$13M
Filed 05/11
Traded 05/11
- Robert W. Duggan
BuyPulse Biosciences
BuyPulse Biosciences
PLSE
$2.1M
145,140 sh
$2.1M
Filed 25/09/12
Traded 24/09/12
